Physical exercise is generally beneficial against cognition decline, which is associated with reduced inflammation in the hippocampus. Yet, little is known about the mechanisms. CLU, also known as apolipoprotein J, is a multifunctional glycoprotein present in plasma [
154]. CLU expression is near-ubiquitous, and CLU mRNA is found in almost all cell types. CLU expression is increased in response to a broad variety of signals and conditions, including the presence of oncogenes, numerous growth factors and cytokines, as well as many stress- or apoptosis-inducing conditions/agents such as heat shock, UVA, UVB, proteotoxic stress, heavy metals, oxidants, hypoxia, ionizing radiation, and chemotherapeutic drugs [
44]. Recently, a study found that injecting the ‘exercise plasma’ collected from voluntarily running mice into the sedentary mice induces reductions in baseline expression of neuroinflammatory genes and experimentally induced brain inflammation [
155]. The authors also performed a proteomic analysis of the plasma composition in exercising mice and found that the levels of specific cytokines, such as CLU, glycoprotein pigment epithelium-derived factor (PEDF), and leukemia inhibitory factor receptor (LIFR), are increased after exercise [
155]. When mice were further injected with exercise plasma without CLU, PEDF, or LIFR, the gene expression and protein levels of anti-inflammatory factors were significantly reduced in the CLU-deficient mice. Moreover, the researchers found increased plasma CLU levels as well as improved cognition and memory in patients with MCI after 6 months of physical activity intervention [
155]. LRP8, also known as APOER2, is the receptor of CLU [
156] and expressed most highly in brain endothelial cells and neurons [
155]. This indicates that elevated CLU in blood may bind to brain endothelial cells through LRP8 receptors and benefit the brain. Protein aggregation is a common pathological hallmark across neurodegenerative diseases. Similar to CLU co-localizing with Aβ in the senile plaques, in the case of α-synucleinopathies, CLU co-localizes with cortical Lewy bodies in the brain. Moreover, the co-expression of CLU may protect neurons from proteotoxicity [
157]. In mice injected intravenously with recombinant clusterin (rCLU) labelled with Atto-647 N fluorophore, researchers found a prominent decoration of the cerebrovasculature of the hippocampus with Atto-647 N-rCLU [
155], which demonstrated that endothelial cells and neurons may be the immediate target of circulatory CLU.